Activation of the hedgehog pathway in human hepatocellular carcinomas

Shuhong Huang, Jing He, Xiaoli Zhang, Yuehong Bian, Ling Yang, Guorui Xie, Kefei Zhang, Wendell Tang, Arwen A. Stelter, Qian Wang, Hongwei Zhang, Jingwu Xie

Research output: Contribution to journalArticle

166 Citations (Scopus)

Abstract

Liver cancers, the majority of which are hepatocellular carcinomas (HCCs), rank as the fourth in cancer mortality worldwide and are the most rapidly increasing type of cancer in the United States. However, the molecular mechanisms underlying HCC development are not well understood. Activation of the hedgehog pathway is shown to be involved in several types of gastrointestinal cancers. Here, we provide evidence to indicate that hedgehog signaling activation occurs frequently in HCC. We detect expression of Shh, PTCH1 and Gli1 in 115 cases of HCC and in 44 liver tissues adjacent to the tumor. Expression of Shh is detectable in about 60% of HCCs examined. Consistent with this, hedgehog target genes PTCH1 and Gli1 are expressed in over 50% of the tumors, suggesting that the hedgehog pathway is frequently activated in HCCs. Of five cell lines screened, we found Hep3B, Huh7 and PLC/PRF/5 cells with detectable hedgehog target genes. Specific inhibition of hedgehog signaling in these three cell lines by smoothened (SMO) antagonist, KAAD-cyclopamine, or with Shh neutralizing antibodies decreases expression of hedgehog target genes, inhibits cell growth and results in apoptosis. In contrast, no effects are observed after these treatments in HCC36 and HepG2 cells, which do not have detectable hedgehog signaling. Thus, our data indicate that hedgehog signaling activation is an important event for development of human HCCs.

Original languageEnglish (US)
Pages (from-to)1334-1340
Number of pages7
JournalCarcinogenesis
Volume27
Issue number7
DOIs
StatePublished - Jul 2006
Externally publishedYes

Fingerprint

Hepatocellular Carcinoma
Neoplasms
Genes
Cell Line
Gastrointestinal Neoplasms
Hep G2 Cells
Human Development
Liver Neoplasms
Neutralizing Antibodies
Apoptosis
Mortality
Liver
Growth

ASJC Scopus subject areas

  • Cancer Research

Cite this

Activation of the hedgehog pathway in human hepatocellular carcinomas. / Huang, Shuhong; He, Jing; Zhang, Xiaoli; Bian, Yuehong; Yang, Ling; Xie, Guorui; Zhang, Kefei; Tang, Wendell; Stelter, Arwen A.; Wang, Qian; Zhang, Hongwei; Xie, Jingwu.

In: Carcinogenesis, Vol. 27, No. 7, 07.2006, p. 1334-1340.

Research output: Contribution to journalArticle

Huang, S, He, J, Zhang, X, Bian, Y, Yang, L, Xie, G, Zhang, K, Tang, W, Stelter, AA, Wang, Q, Zhang, H & Xie, J 2006, 'Activation of the hedgehog pathway in human hepatocellular carcinomas', Carcinogenesis, vol. 27, no. 7, pp. 1334-1340. https://doi.org/10.1093/carcin/bgi378
Huang S, He J, Zhang X, Bian Y, Yang L, Xie G et al. Activation of the hedgehog pathway in human hepatocellular carcinomas. Carcinogenesis. 2006 Jul;27(7):1334-1340. https://doi.org/10.1093/carcin/bgi378
Huang, Shuhong ; He, Jing ; Zhang, Xiaoli ; Bian, Yuehong ; Yang, Ling ; Xie, Guorui ; Zhang, Kefei ; Tang, Wendell ; Stelter, Arwen A. ; Wang, Qian ; Zhang, Hongwei ; Xie, Jingwu. / Activation of the hedgehog pathway in human hepatocellular carcinomas. In: Carcinogenesis. 2006 ; Vol. 27, No. 7. pp. 1334-1340.
@article{43c747802c1447bb88b17fb2c3cb9431,
title = "Activation of the hedgehog pathway in human hepatocellular carcinomas",
abstract = "Liver cancers, the majority of which are hepatocellular carcinomas (HCCs), rank as the fourth in cancer mortality worldwide and are the most rapidly increasing type of cancer in the United States. However, the molecular mechanisms underlying HCC development are not well understood. Activation of the hedgehog pathway is shown to be involved in several types of gastrointestinal cancers. Here, we provide evidence to indicate that hedgehog signaling activation occurs frequently in HCC. We detect expression of Shh, PTCH1 and Gli1 in 115 cases of HCC and in 44 liver tissues adjacent to the tumor. Expression of Shh is detectable in about 60{\%} of HCCs examined. Consistent with this, hedgehog target genes PTCH1 and Gli1 are expressed in over 50{\%} of the tumors, suggesting that the hedgehog pathway is frequently activated in HCCs. Of five cell lines screened, we found Hep3B, Huh7 and PLC/PRF/5 cells with detectable hedgehog target genes. Specific inhibition of hedgehog signaling in these three cell lines by smoothened (SMO) antagonist, KAAD-cyclopamine, or with Shh neutralizing antibodies decreases expression of hedgehog target genes, inhibits cell growth and results in apoptosis. In contrast, no effects are observed after these treatments in HCC36 and HepG2 cells, which do not have detectable hedgehog signaling. Thus, our data indicate that hedgehog signaling activation is an important event for development of human HCCs.",
author = "Shuhong Huang and Jing He and Xiaoli Zhang and Yuehong Bian and Ling Yang and Guorui Xie and Kefei Zhang and Wendell Tang and Stelter, {Arwen A.} and Qian Wang and Hongwei Zhang and Jingwu Xie",
year = "2006",
month = "7",
doi = "10.1093/carcin/bgi378",
language = "English (US)",
volume = "27",
pages = "1334--1340",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Activation of the hedgehog pathway in human hepatocellular carcinomas

AU - Huang, Shuhong

AU - He, Jing

AU - Zhang, Xiaoli

AU - Bian, Yuehong

AU - Yang, Ling

AU - Xie, Guorui

AU - Zhang, Kefei

AU - Tang, Wendell

AU - Stelter, Arwen A.

AU - Wang, Qian

AU - Zhang, Hongwei

AU - Xie, Jingwu

PY - 2006/7

Y1 - 2006/7

N2 - Liver cancers, the majority of which are hepatocellular carcinomas (HCCs), rank as the fourth in cancer mortality worldwide and are the most rapidly increasing type of cancer in the United States. However, the molecular mechanisms underlying HCC development are not well understood. Activation of the hedgehog pathway is shown to be involved in several types of gastrointestinal cancers. Here, we provide evidence to indicate that hedgehog signaling activation occurs frequently in HCC. We detect expression of Shh, PTCH1 and Gli1 in 115 cases of HCC and in 44 liver tissues adjacent to the tumor. Expression of Shh is detectable in about 60% of HCCs examined. Consistent with this, hedgehog target genes PTCH1 and Gli1 are expressed in over 50% of the tumors, suggesting that the hedgehog pathway is frequently activated in HCCs. Of five cell lines screened, we found Hep3B, Huh7 and PLC/PRF/5 cells with detectable hedgehog target genes. Specific inhibition of hedgehog signaling in these three cell lines by smoothened (SMO) antagonist, KAAD-cyclopamine, or with Shh neutralizing antibodies decreases expression of hedgehog target genes, inhibits cell growth and results in apoptosis. In contrast, no effects are observed after these treatments in HCC36 and HepG2 cells, which do not have detectable hedgehog signaling. Thus, our data indicate that hedgehog signaling activation is an important event for development of human HCCs.

AB - Liver cancers, the majority of which are hepatocellular carcinomas (HCCs), rank as the fourth in cancer mortality worldwide and are the most rapidly increasing type of cancer in the United States. However, the molecular mechanisms underlying HCC development are not well understood. Activation of the hedgehog pathway is shown to be involved in several types of gastrointestinal cancers. Here, we provide evidence to indicate that hedgehog signaling activation occurs frequently in HCC. We detect expression of Shh, PTCH1 and Gli1 in 115 cases of HCC and in 44 liver tissues adjacent to the tumor. Expression of Shh is detectable in about 60% of HCCs examined. Consistent with this, hedgehog target genes PTCH1 and Gli1 are expressed in over 50% of the tumors, suggesting that the hedgehog pathway is frequently activated in HCCs. Of five cell lines screened, we found Hep3B, Huh7 and PLC/PRF/5 cells with detectable hedgehog target genes. Specific inhibition of hedgehog signaling in these three cell lines by smoothened (SMO) antagonist, KAAD-cyclopamine, or with Shh neutralizing antibodies decreases expression of hedgehog target genes, inhibits cell growth and results in apoptosis. In contrast, no effects are observed after these treatments in HCC36 and HepG2 cells, which do not have detectable hedgehog signaling. Thus, our data indicate that hedgehog signaling activation is an important event for development of human HCCs.

UR - http://www.scopus.com/inward/record.url?scp=33745634379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745634379&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgi378

DO - 10.1093/carcin/bgi378

M3 - Article

C2 - 16501253

AN - SCOPUS:33745634379

VL - 27

SP - 1334

EP - 1340

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 7

ER -